Game-changer for diabetes? Tandem’s Control-IQ+ automated insulin delivery system now available in the US
Tandem Diabetes Care launches Control-IQ+ automated insulin delivery for type 1 and type 2 diabetes, expanding access to advanced insulin automation in the U.S. Read More
Insulin patch pump developer AMF Medical to be acquired by Tandem Diabetes Care
Tandem Diabetes Care, an American diabetes technology company, has agreed to acquire Switzerland-based insulin patch pump developer AMF Medical SA for CHF 62.4 million, which ... Read More